Study Design and Participants
stroke, TICH-NOAC
STROKE
TICH-NOAC was a double-blind, randomized, placebo-controlled, investigator-led phase 2 trial conducted at 6 stroke centers in Switzerland (TICH-NOAC was performed and reported in accordance with the study protocol and prespecified statistical analysis plan (under version control; latest version 1.4 [dated April 16, 2020] made available online at 